| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | 7.33e-08 | 749 | 5 | 5 | GO:0005509 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 8.10e-06 | 188 | 5 | 3 | GO:0005201 | |
| GeneOntologyMolecularFunction | heparin binding | 8.63e-06 | 192 | 5 | 3 | GO:0008201 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 2.34e-05 | 268 | 5 | 3 | GO:0005539 | |
| GeneOntologyMolecularFunction | fibronectin binding | 3.51e-05 | 38 | 5 | 2 | GO:0001968 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 4.09e-05 | 323 | 5 | 3 | GO:1901681 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 6.36e-05 | 51 | 5 | 2 | GO:0043394 | |
| GeneOntologyMolecularFunction | collagen binding | 1.61e-04 | 81 | 5 | 2 | GO:0005518 | |
| GeneOntologyMolecularFunction | cytokine binding | 6.05e-04 | 157 | 5 | 2 | GO:0019955 | |
| GeneOntologyMolecularFunction | integrin binding | 7.51e-04 | 175 | 5 | 2 | GO:0005178 | |
| GeneOntologyMolecularFunction | protease binding | 8.03e-04 | 181 | 5 | 2 | GO:0002020 | |
| GeneOntologyMolecularFunction | structural molecule activity | 8.28e-04 | 891 | 5 | 3 | GO:0005198 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 8.46e-03 | 599 | 5 | 2 | GO:0050839 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 1.53e-02 | 815 | 5 | 2 | GO:0042803 | |
| GeneOntologyMolecularFunction | lipid binding | 2.21e-02 | 988 | 5 | 2 | GO:0008289 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 3.22e-02 | 1205 | 5 | 2 | GO:0046983 | |
| GeneOntologyBiologicalProcess | growth plate cartilage development | 1.90e-05 | 29 | 5 | 2 | GO:0003417 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 3.26e-05 | 309 | 5 | 3 | GO:1901888 | |
| GeneOntologyBiologicalProcess | endochondral bone growth | 3.47e-05 | 39 | 5 | 2 | GO:0003416 | |
| GeneOntologyBiologicalProcess | bone growth | 4.63e-05 | 45 | 5 | 2 | GO:0098868 | |
| GeneOntologyBiologicalProcess | cartilage development involved in endochondral bone morphogenesis | 5.06e-05 | 47 | 5 | 2 | GO:0060351 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 1.13e-04 | 70 | 5 | 2 | GO:1900047 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 1.44e-04 | 79 | 5 | 2 | GO:0060350 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 1.99e-04 | 93 | 5 | 2 | GO:1900046 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 2.00e-04 | 569 | 5 | 3 | GO:0034329 | |
| GeneOntologyBiologicalProcess | bone morphogenesis | 3.54e-04 | 124 | 5 | 2 | GO:0060349 | |
| GeneOntologyBiologicalProcess | regulation of ossification | 4.97e-04 | 147 | 5 | 2 | GO:0030278 | |
| GeneOntologyBiologicalProcess | response to unfolded protein | 5.04e-04 | 148 | 5 | 2 | GO:0006986 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 5.83e-04 | 817 | 5 | 3 | GO:0048514 | |
| GeneOntologyBiologicalProcess | endocytosis | 6.04e-04 | 827 | 5 | 3 | GO:0006897 | |
| GeneOntologyBiologicalProcess | response to topologically incorrect protein | 6.34e-04 | 166 | 5 | 2 | GO:0035966 | |
| GeneOntologyBiologicalProcess | negative regulation of angiogenesis | 7.04e-04 | 175 | 5 | 2 | GO:0016525 | |
| GeneOntologyBiologicalProcess | negative regulation of blood vessel morphogenesis | 7.28e-04 | 178 | 5 | 2 | GO:2000181 | |
| GeneOntologyBiologicalProcess | negative regulation of vasculature development | 7.44e-04 | 180 | 5 | 2 | GO:1901343 | |
| GeneOntologyBiologicalProcess | developmental growth | 8.03e-04 | 911 | 5 | 3 | GO:0048589 | |
| GeneOntologyBiologicalProcess | blood vessel development | 8.51e-04 | 929 | 5 | 3 | GO:0001568 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 9.36e-04 | 202 | 5 | 2 | GO:0051963 | |
| GeneOntologyBiologicalProcess | vasculature development | 9.63e-04 | 969 | 5 | 3 | GO:0001944 | |
| GeneOntologyBiologicalProcess | cell junction organization | 9.77e-04 | 974 | 5 | 3 | GO:0034330 | |
| GeneOntologyBiologicalProcess | limb development | 1.15e-03 | 224 | 5 | 2 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 1.15e-03 | 224 | 5 | 2 | GO:0048736 | |
| GeneOntologyBiologicalProcess | import into cell | 1.30e-03 | 1074 | 5 | 3 | GO:0098657 | |
| GeneOntologyBiologicalProcess | cartilage development | 1.35e-03 | 243 | 5 | 2 | GO:0051216 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | 1.36e-03 | 1090 | 5 | 3 | GO:0022603 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 1.49e-03 | 1125 | 5 | 3 | GO:0035239 | |
| GeneOntologyBiologicalProcess | organ growth | 1.50e-03 | 256 | 5 | 2 | GO:0035265 | |
| GeneOntologyBiologicalProcess | blood coagulation | 1.54e-03 | 260 | 5 | 2 | GO:0007596 | |
| GeneOntologyBiologicalProcess | bone development | 1.59e-03 | 264 | 5 | 2 | GO:0060348 | |
| GeneOntologyBiologicalProcess | coagulation | 1.61e-03 | 266 | 5 | 2 | GO:0050817 | |
| GeneOntologyBiologicalProcess | hemostasis | 1.64e-03 | 268 | 5 | 2 | GO:0007599 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 1.74e-03 | 1186 | 5 | 3 | GO:0007167 | |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 1.75e-03 | 277 | 5 | 2 | GO:0048705 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | 1.75e-03 | 1189 | 5 | 3 | GO:0044087 | |
| GeneOntologyBiologicalProcess | protein processing | 1.85e-03 | 285 | 5 | 2 | GO:0016485 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | 1.89e-03 | 1220 | 5 | 3 | GO:0051093 | |
| GeneOntologyBiologicalProcess | growth | 1.95e-03 | 1235 | 5 | 3 | GO:0040007 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 2.11e-03 | 1269 | 5 | 3 | GO:0009887 | |
| GeneOntologyBiologicalProcess | synapse assembly | 2.16e-03 | 308 | 5 | 2 | GO:0007416 | |
| GeneOntologyBiologicalProcess | connective tissue development | 2.67e-03 | 343 | 5 | 2 | GO:0061448 | |
| GeneOntologyBiologicalProcess | tube development | 2.82e-03 | 1402 | 5 | 3 | GO:0035295 | |
| GeneOntologyBiologicalProcess | circulatory system development | 3.06e-03 | 1442 | 5 | 3 | GO:0072359 | |
| GeneOntologyBiologicalProcess | skin development | 3.15e-03 | 373 | 5 | 2 | GO:0043588 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | 3.35e-03 | 1488 | 5 | 3 | GO:0051241 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 3.38e-03 | 387 | 5 | 2 | GO:0050807 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 3.52e-03 | 395 | 5 | 2 | GO:0050803 | |
| GeneOntologyBiologicalProcess | regulation of angiogenesis | 3.97e-03 | 420 | 5 | 2 | GO:0045765 | |
| GeneOntologyBiologicalProcess | regulation of vasculature development | 4.16e-03 | 430 | 5 | 2 | GO:1901342 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | 4.39e-03 | 442 | 5 | 2 | GO:0050878 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 4.45e-03 | 445 | 5 | 2 | GO:0141091 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.56e-04 | 530 | 5 | 3 | GO:0062023 | |
| GeneOntologyCellularComponent | platelet alpha granule | 1.94e-04 | 93 | 5 | 2 | GO:0031091 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.93e-04 | 656 | 5 | 3 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.96e-04 | 658 | 5 | 3 | GO:0030312 | |
| HumanPheno | Abnormal carpal morphology | 3.16e-04 | 91 | 2 | 2 | HP:0001191 | |
| HumanPheno | Abnormality of the musculature of the hand | 5.97e-04 | 125 | 2 | 2 | HP:0001421 | |
| HumanPheno | Abnormality of the ulna | 9.68e-04 | 159 | 2 | 2 | HP:0002997 | |
| HumanPheno | Abnormal morphology of ulna | 9.68e-04 | 159 | 2 | 2 | HP:0040071 | |
| HumanPheno | Abnormality of the wrist | 1.08e-03 | 168 | 2 | 2 | HP:0003019 | |
| HumanPheno | Abnormal distal phalanx morphology of finger | 1.16e-03 | 174 | 2 | 2 | HP:0009832 | |
| HumanPheno | Abnormal forearm bone morphology | 1.27e-03 | 182 | 2 | 2 | HP:0040073 | |
| HumanPheno | Abnormal morphology of the radius | 1.81e-03 | 217 | 2 | 2 | HP:0002818 | |
| HumanPheno | Abnormality of the metacarpal bones | 1.99e-03 | 228 | 2 | 2 | HP:0001163 | |
| HumanPheno | Abnormal metacarpal morphology | 1.99e-03 | 228 | 2 | 2 | HP:0005916 | |
| HumanPheno | Abnormal forearm bone morphology | 2.14e-03 | 236 | 2 | 2 | HP:0040072 | |
| HumanPheno | Abnormal forearm morphology | 2.19e-03 | 239 | 2 | 2 | HP:0002973 | |
| HumanPheno | Abnormal shoulder morphology | 2.32e-03 | 246 | 2 | 2 | HP:0003043 | |
| HumanPheno | Short long bone | 2.97e-03 | 278 | 2 | 2 | HP:0003026 | |
| HumanPheno | Abnormality of the elbow | 3.05e-03 | 282 | 2 | 2 | HP:0009811 | |
| HumanPheno | Abnormality of the musculature of the upper limbs | 3.08e-03 | 283 | 2 | 2 | HP:0001446 | |
| HumanPheno | Bowing of the long bones | 3.84e-03 | 316 | 2 | 2 | HP:0006487 | |
| HumanPheno | Anomaly of the limb diaphyses | 3.98e-03 | 322 | 2 | 2 | HP:0006504 | |
| HumanPheno | Short finger | 4.06e-03 | 325 | 2 | 2 | HP:0009381 | |
| HumanPheno | Abnormal rib morphology | 4.34e-03 | 336 | 2 | 2 | HP:0000772 | |
| HumanPheno | Myopathy | 4.47e-03 | 341 | 2 | 2 | HP:0003198 | |
| HumanPheno | Abnormal diaphysis morphology | 4.52e-03 | 343 | 2 | 2 | HP:0000940 | |
| HumanPheno | Abnormal form of the vertebral bodies | 4.65e-03 | 348 | 2 | 2 | HP:0003312 | |
| HumanPheno | Aplasia/Hypoplasia of fingers | 5.15e-03 | 366 | 2 | 2 | HP:0006265 | |
| HumanPheno | Brachydactyly (hand) | 7.11e-03 | 430 | 2 | 2 | HP:0100667 | |
| HumanPheno | Functional motor deficit | 7.31e-03 | 436 | 2 | 2 | HP:0004302 | |
| HumanPheno | Abnormal morphology of bones of the upper limbs | 7.31e-03 | 436 | 2 | 2 | HP:0040065 | |
| HumanPheno | Limb undergrowth | 7.58e-03 | 444 | 2 | 2 | HP:0009826 | |
| HumanPheno | Abnormal rib cage morphology | 7.62e-03 | 445 | 2 | 2 | HP:0001547 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the lower limbs | 8.64e-03 | 474 | 2 | 2 | HP:0006493 | |
| HumanPheno | Abnormal vertebral morphology | 8.97e-03 | 483 | 2 | 2 | HP:0003468 | |
| MousePheno | abnormal tendon morphology | 4.74e-05 | 31 | 5 | 2 | MP:0005503 | |
| MousePheno | increased compact bone thickness | 8.35e-05 | 41 | 5 | 2 | MP:0004148 | |
| MousePheno | abnormal spine curvature | 1.13e-04 | 318 | 5 | 3 | MP:0004174 | |
| MousePheno | limbs/digits/tail phenotype | 3.03e-04 | 1258 | 5 | 4 | MP:0005371 | |
| MousePheno | abnormal chondrocyte morphology | 3.44e-04 | 83 | 5 | 2 | MP:0000166 | |
| MousePheno | abnormal hindlimb morphology | 6.54e-04 | 576 | 5 | 3 | MP:0000556 | |
| MousePheno | abnormal compact bone thickness | 7.43e-04 | 122 | 5 | 2 | MP:0000134 | |
| MousePheno | abnormal response to injury | 7.63e-04 | 607 | 5 | 3 | MP:0005164 | |
| MousePheno | abnormal compact bone morphology | 1.47e-03 | 172 | 5 | 2 | MP:0003797 | |
| MousePheno | abnormal vertebral column morphology | 1.63e-03 | 787 | 5 | 3 | MP:0004703 | |
| MousePheno | abnormal wound healing | 1.85e-03 | 193 | 5 | 2 | MP:0005023 | |
| MousePheno | abnormal exocrine gland morphology | 2.06e-03 | 853 | 5 | 3 | MP:0013558 | |
| MousePheno | abnormal femur morphology | 2.26e-03 | 214 | 5 | 2 | MP:0000559 | |
| MousePheno | abnormal hindlimb stylopod morphology | 2.28e-03 | 215 | 5 | 2 | MP:0003856 | |
| MousePheno | decreased apoptosis | 2.37e-03 | 219 | 5 | 2 | MP:0006043 | |
| MousePheno | decreased cell death | 2.45e-03 | 223 | 5 | 2 | MP:0012555 | |
| MousePheno | kyphosis | 2.59e-03 | 229 | 5 | 2 | MP:0000160 | |
| MousePheno | abnormal limb morphology | 3.54e-03 | 1028 | 5 | 3 | MP:0002109 | |
| MousePheno | abnormal skin physiology | 4.06e-03 | 288 | 5 | 2 | MP:0005501 | |
| MousePheno | abnormal muscle morphology | 4.37e-03 | 1106 | 5 | 3 | MP:0002108 | |
| MousePheno | abnormal cartilage morphology | 5.49e-03 | 336 | 5 | 2 | MP:0000163 | |
| MousePheno | abnormal angiogenesis | 6.70e-03 | 372 | 5 | 2 | MP:0000260 | |
| Domain | EGF_CA | 1.84e-12 | 86 | 5 | 5 | PF07645 | |
| Domain | EGF_CA | 1.10e-11 | 122 | 5 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.19e-11 | 124 | 5 | 5 | IPR001881 | |
| Domain | TSP_type-3_rpt | 9.21e-11 | 5 | 5 | 3 | IPR028974 | |
| Domain | TSP_3 | 9.21e-11 | 5 | 5 | 3 | PF02412 | |
| Domain | Thrombospondin_C | 9.21e-11 | 5 | 5 | 3 | IPR008859 | |
| Domain | Thrombospondin_3-like_rpt | 9.21e-11 | 5 | 5 | 3 | IPR003367 | |
| Domain | TSP_C | 9.21e-11 | 5 | 5 | 3 | PF05735 | |
| Domain | TSP3 | 9.21e-11 | 5 | 5 | 3 | PS51234 | |
| Domain | TSP_CTER | 9.21e-11 | 5 | 5 | 3 | PS51236 | |
| Domain | Thrombospondin_3_rpt | 9.21e-11 | 5 | 5 | 3 | IPR017897 | |
| Domain | - | 9.21e-11 | 5 | 5 | 3 | 4.10.1080.10 | |
| Domain | EGF | 3.02e-10 | 235 | 5 | 5 | SM00181 | |
| Domain | EGF_3 | 3.02e-10 | 235 | 5 | 5 | PS50026 | |
| Domain | EGF-like_dom | 4.05e-10 | 249 | 5 | 5 | IPR000742 | |
| Domain | EGF_1 | 4.56e-10 | 255 | 5 | 5 | PS00022 | |
| Domain | EGF-like_CS | 5.13e-10 | 261 | 5 | 5 | IPR013032 | |
| Domain | EGF_2 | 5.54e-10 | 265 | 5 | 5 | PS01186 | |
| Domain | - | 1.27e-06 | 95 | 5 | 3 | 2.60.120.200 | |
| Domain | EGF_Ca-bd_CS | 1.35e-06 | 97 | 5 | 3 | IPR018097 | |
| Domain | EGF_CA | 1.43e-06 | 99 | 5 | 3 | PS01187 | |
| Domain | EGF | 2.97e-06 | 126 | 5 | 3 | PF00008 | |
| Domain | Ldl_recept_b | 5.21e-06 | 14 | 5 | 2 | PF00058 | |
| Domain | LDLRB | 5.21e-06 | 14 | 5 | 2 | PS51120 | |
| Domain | Growth_fac_rcpt_ | 5.65e-06 | 156 | 5 | 3 | IPR009030 | |
| Domain | LY | 6.01e-06 | 15 | 5 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 6.01e-06 | 15 | 5 | 2 | IPR000033 | |
| Domain | TSPN | 1.45e-05 | 23 | 5 | 2 | SM00210 | |
| Domain | ConA-like_dom | 1.56e-05 | 219 | 5 | 3 | IPR013320 | |
| Domain | cEGF | 1.86e-05 | 26 | 5 | 2 | PF12662 | |
| Domain | cEGF | 1.86e-05 | 26 | 5 | 2 | IPR026823 | |
| Domain | VWC | 2.16e-05 | 28 | 5 | 2 | PF00093 | |
| Domain | VWFC_1 | 3.60e-05 | 36 | 5 | 2 | PS01208 | |
| Domain | VWFC_2 | 4.02e-05 | 38 | 5 | 2 | PS50184 | |
| Domain | VWC | 4.02e-05 | 38 | 5 | 2 | SM00214 | |
| Domain | - | 4.23e-05 | 39 | 5 | 2 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 4.45e-05 | 40 | 5 | 2 | IPR023415 | |
| Domain | VWF_dom | 4.92e-05 | 42 | 5 | 2 | IPR001007 | |
| Domain | Ldl_recept_a | 5.65e-05 | 45 | 5 | 2 | PF00057 | |
| Domain | - | 5.91e-05 | 46 | 5 | 2 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 5.91e-05 | 46 | 5 | 2 | IPR011042 | |
| Domain | LDLRA_1 | 6.44e-05 | 48 | 5 | 2 | PS01209 | |
| Domain | LDLa | 6.71e-05 | 49 | 5 | 2 | SM00192 | |
| Domain | LDLRA_2 | 6.71e-05 | 49 | 5 | 2 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 6.71e-05 | 49 | 5 | 2 | IPR002172 | |
| Domain | Laminin_G | 9.42e-05 | 58 | 5 | 2 | IPR001791 | |
| Domain | TSP_1 | 1.11e-04 | 63 | 5 | 2 | PF00090 | |
| Domain | TSP1_rpt | 1.18e-04 | 65 | 5 | 2 | IPR000884 | |
| Domain | TSP1 | 1.18e-04 | 65 | 5 | 2 | PS50092 | |
| Domain | TSP1 | 1.18e-04 | 65 | 5 | 2 | SM00209 | |
| Domain | ASX_HYDROXYL | 2.81e-04 | 100 | 5 | 2 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.16e-04 | 106 | 5 | 2 | IPR000152 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.02e-06 | 84 | 5 | 3 | M7098 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 2.17e-06 | 86 | 5 | 3 | M2642 | |
| Pathway | WP_FOCAL_ADHESION | 2.71e-05 | 199 | 5 | 3 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 2.71e-05 | 199 | 5 | 3 | M7253 | |
| Pathway | PID_INTEGRIN_A4B1_PATHWAY | 5.29e-05 | 33 | 5 | 2 | M277 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 7.42e-05 | 39 | 5 | 2 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 7.42e-05 | 39 | 5 | 2 | MM15165 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 9.04e-05 | 43 | 5 | 2 | M39565 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 9.24e-05 | 300 | 5 | 3 | M610 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 9.43e-05 | 302 | 5 | 3 | M39719 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.18e-04 | 326 | 5 | 3 | MM15917 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.33e-04 | 339 | 5 | 3 | M39736 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.59e-04 | 57 | 5 | 2 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.65e-04 | 58 | 5 | 2 | M2049 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.14e-04 | 66 | 5 | 2 | M18 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.27e-04 | 68 | 5 | 2 | M27303 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.84e-04 | 76 | 5 | 2 | M27219 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.84e-04 | 76 | 5 | 2 | MM14867 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.55e-04 | 85 | 5 | 2 | M16441 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 5.83e-04 | 109 | 5 | 2 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 6.05e-04 | 111 | 5 | 2 | M27416 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.00e-03 | 143 | 5 | 2 | M27275 | |
| Pathway | WP_FOCAL_ADHESION | 1.70e-03 | 187 | 5 | 2 | MM15913 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.02e-03 | 250 | 5 | 2 | M27554 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.22e-03 | 258 | 5 | 2 | MM14572 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 6.90e-03 | 381 | 5 | 2 | M48063 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 8.27e-03 | 418 | 5 | 2 | MM15587 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.32e-02 | 532 | 5 | 2 | M27870 | |
| Pubmed | Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology. | 1.43e-12 | 3 | 5 | 3 | 26168731 | |
| Pubmed | 1.43e-11 | 5 | 5 | 3 | 30622267 | ||
| Pubmed | Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear. | 7.99e-11 | 8 | 5 | 3 | 24460873 | |
| Pubmed | Induced thrombospondin expression in the mouse pancreas during pancreatic injury. | 1.65e-08 | 2 | 5 | 2 | 16181801 | |
| Pubmed | Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis. | 1.65e-08 | 2 | 5 | 2 | 15037577 | |
| Pubmed | 1.65e-08 | 2 | 5 | 2 | 38339060 | ||
| Pubmed | Intermolecular interactions of thrombospondins drive their accumulation in extracellular matrix. | 1.65e-08 | 2 | 5 | 2 | 25995382 | |
| Pubmed | Expression of thrombospondin-1 in ischemia-induced retinal neovascularization. | 1.65e-08 | 2 | 5 | 2 | 10027393 | |
| Pubmed | 1.65e-08 | 2 | 5 | 2 | 17620335 | ||
| Pubmed | 1.65e-08 | 2 | 5 | 2 | 33372257 | ||
| Pubmed | 1.65e-08 | 2 | 5 | 2 | 21762961 | ||
| Pubmed | 1.65e-08 | 2 | 5 | 2 | 30928339 | ||
| Pubmed | Human cytomegalovirus infection modulates thrombospondins 1 and 2 in primary fetal astrocytes. | 1.65e-08 | 2 | 5 | 2 | 23660684 | |
| Pubmed | 1.65e-08 | 2 | 5 | 2 | 9694593 | ||
| Pubmed | 1.65e-08 | 2 | 5 | 2 | 39122122 | ||
| Pubmed | 1.65e-08 | 2 | 5 | 2 | 34425286 | ||
| Pubmed | 1.65e-08 | 2 | 5 | 2 | 12213711 | ||
| Pubmed | Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures. | 1.65e-08 | 2 | 5 | 2 | 22930728 | |
| Pubmed | 1.65e-08 | 2 | 5 | 2 | 17143334 | ||
| Pubmed | Circulating Levels of Thrombospondin-1 and Thrombospondin-2 in Patients with Common Brain Tumors. | 1.65e-08 | 2 | 5 | 2 | 33759165 | |
| Pubmed | Modulation of thrombospondin expression during differentiation of embryonal carcinoma cells. | 1.65e-08 | 2 | 5 | 2 | 8126073 | |
| Pubmed | 1.65e-08 | 2 | 5 | 2 | 33981184 | ||
| Pubmed | 1.65e-08 | 2 | 5 | 2 | 23875975 | ||
| Pubmed | Thrombospondin expression in aldosterone-producing adenomas. | 1.65e-08 | 2 | 5 | 2 | 12358136 | |
| Pubmed | Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. | 1.65e-08 | 2 | 5 | 2 | 18594557 | |
| Pubmed | A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome. | 1.65e-08 | 2 | 5 | 2 | 1712771 | |
| Pubmed | Reduced expression of thrombospondins and craniofacial dysmorphism in mice overexpressing Fra1. | 4.96e-08 | 3 | 5 | 2 | 16598380 | |
| Pubmed | 4.96e-08 | 3 | 5 | 2 | 26241338 | ||
| Pubmed | 4.96e-08 | 3 | 5 | 2 | 9373030 | ||
| Pubmed | 4.96e-08 | 3 | 5 | 2 | 27513329 | ||
| Pubmed | Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury. | 4.96e-08 | 3 | 5 | 2 | 18787106 | |
| Pubmed | 4.96e-08 | 3 | 5 | 2 | 15347840 | ||
| Pubmed | 4.96e-08 | 3 | 5 | 2 | 30939949 | ||
| Pubmed | Extracellular matrix retention of thrombospondin 1 is controlled by its conserved C-terminal region. | 4.96e-08 | 3 | 5 | 2 | 18285447 | |
| Pubmed | 4.96e-08 | 3 | 5 | 2 | 18032585 | ||
| Pubmed | 4.96e-08 | 3 | 5 | 2 | 18178577 | ||
| Pubmed | 4.96e-08 | 3 | 5 | 2 | 25976449 | ||
| Pubmed | Interactions between CD47 and thrombospondin reduce inflammation. | 4.96e-08 | 3 | 5 | 2 | 17442977 | |
| Pubmed | 4.96e-08 | 3 | 5 | 2 | 19004835 | ||
| Pubmed | Differential expression of thrombospondin 1, 2, and 3 during murine development. | 4.96e-08 | 3 | 5 | 2 | 8400410 | |
| Pubmed | Thrombospondin is a tight-binding competitive inhibitor of neutrophil elastase. | 4.96e-08 | 3 | 5 | 2 | 8463250 | |
| Pubmed | 4.96e-08 | 3 | 5 | 2 | 31092423 | ||
| Pubmed | 4.96e-08 | 3 | 5 | 2 | 19818485 | ||
| Pubmed | Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction. | 4.96e-08 | 3 | 5 | 2 | 12482844 | |
| Pubmed | 4.96e-08 | 3 | 5 | 2 | 25712208 | ||
| Pubmed | 4.96e-08 | 3 | 5 | 2 | 34669362 | ||
| Pubmed | Thrombospondin 1 and thrombospondin 2 are expressed as both homo- and heterotrimers. | 4.96e-08 | 3 | 5 | 2 | 1459996 | |
| Pubmed | 4.96e-08 | 3 | 5 | 2 | 33069367 | ||
| Pubmed | EWS/FLI1 regulates tumor angiogenesis in Ewing's sarcoma via suppression of thrombospondins. | 4.96e-08 | 3 | 5 | 2 | 17638877 | |
| Pubmed | 9.92e-08 | 4 | 5 | 2 | 12909644 | ||
| Pubmed | 9.92e-08 | 4 | 5 | 2 | 19147503 | ||
| Pubmed | 9.92e-08 | 4 | 5 | 2 | 11980922 | ||
| Pubmed | 9.92e-08 | 4 | 5 | 2 | 10900205 | ||
| Pubmed | Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets. | 9.92e-08 | 4 | 5 | 2 | 6338048 | |
| Pubmed | 9.92e-08 | 4 | 5 | 2 | 20847111 | ||
| Pubmed | 9.92e-08 | 4 | 5 | 2 | 18089612 | ||
| Pubmed | 1.65e-07 | 5 | 5 | 2 | 20383322 | ||
| Pubmed | 1.65e-07 | 5 | 5 | 2 | 23806329 | ||
| Pubmed | 1.65e-07 | 5 | 5 | 2 | 18467703 | ||
| Pubmed | 5.95e-07 | 9 | 5 | 2 | 1371115 | ||
| Pubmed | 7.20e-07 | 146 | 5 | 3 | 27068509 | ||
| Pubmed | 9.09e-07 | 11 | 5 | 2 | 24639464 | ||
| Pubmed | Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program. | 1.50e-06 | 14 | 5 | 2 | 28729362 | |
| Pubmed | 2.15e-06 | 210 | 5 | 3 | 16537572 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 3.47e-06 | 21 | 5 | 2 | 21337463 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 3.54e-06 | 248 | 5 | 3 | 24006456 | |
| Pubmed | 7.18e-06 | 30 | 5 | 2 | 22171010 | ||
| Pubmed | TBX1 is required for normal stria vascularis and semicircular canal development. | 7.68e-06 | 31 | 5 | 2 | 31550482 | |
| Pubmed | 9.82e-06 | 35 | 5 | 2 | 35858542 | ||
| Pubmed | Myh10 deficiency leads to defective extracellular matrix remodeling and pulmonary disease. | 2.19e-05 | 52 | 5 | 2 | 30389913 | |
| Pubmed | 2.82e-05 | 59 | 5 | 2 | 21421844 | ||
| Pubmed | 4.57e-05 | 75 | 5 | 2 | 20637190 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 6.01e-05 | 86 | 5 | 2 | 28327460 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 8.30e-05 | 101 | 5 | 2 | 20551380 | |
| Pubmed | 1.08e-04 | 115 | 5 | 2 | 20485444 | ||
| Interaction | ZNF563 interactions | 3.25e-06 | 12 | 5 | 2 | int:ZNF563 | |
| Interaction | DEFB123 interactions | 5.90e-06 | 16 | 5 | 2 | int:DEFB123 | |
| Interaction | THBS2 interactions | 8.41e-06 | 19 | 5 | 2 | int:THBS2 | |
| Interaction | ZNF224 interactions | 9.34e-06 | 20 | 5 | 2 | int:ZNF224 | |
| Interaction | NTN5 interactions | 1.36e-05 | 24 | 5 | 2 | int:NTN5 | |
| Interaction | FEZF1 interactions | 1.86e-05 | 28 | 5 | 2 | int:FEZF1 | |
| Interaction | ZFP41 interactions | 7.82e-05 | 57 | 5 | 2 | int:ZFP41 | |
| Interaction | ANKRD36B interactions | 8.67e-05 | 60 | 5 | 2 | int:ANKRD36B | |
| Interaction | HRG interactions | 9.56e-05 | 63 | 5 | 2 | int:HRG | |
| Interaction | ZNF331 interactions | 9.56e-05 | 63 | 5 | 2 | int:ZNF331 | |
| Interaction | COL2A1 interactions | 9.87e-05 | 64 | 5 | 2 | int:COL2A1 | |
| Interaction | MMP9 interactions | 1.08e-04 | 67 | 5 | 2 | int:MMP9 | |
| Interaction | THBS3 interactions | 1.32e-04 | 74 | 5 | 2 | int:THBS3 | |
| Interaction | IGFL3 interactions | 1.36e-04 | 75 | 5 | 2 | int:IGFL3 | |
| Interaction | MMP2 interactions | 1.83e-04 | 87 | 5 | 2 | int:MMP2 | |
| Interaction | DYRK1A interactions | 1.96e-04 | 552 | 5 | 3 | int:DYRK1A | |
| Interaction | FGA interactions | 2.18e-04 | 95 | 5 | 2 | int:FGA | |
| Interaction | FGG interactions | 2.66e-04 | 105 | 5 | 2 | int:FGG | |
| Interaction | LRP5 interactions | 2.87e-04 | 109 | 5 | 2 | int:LRP5 | |
| Interaction | FCGRT interactions | 3.25e-04 | 116 | 5 | 2 | int:FCGRT | |
| Interaction | SULF2 interactions | 3.42e-04 | 119 | 5 | 2 | int:SULF2 | |
| Interaction | THBS1 interactions | 3.89e-04 | 127 | 5 | 2 | int:THBS1 | |
| Interaction | ZSCAN21 interactions | 3.95e-04 | 128 | 5 | 2 | int:ZSCAN21 | |
| Interaction | ZNF408 interactions | 5.07e-04 | 145 | 5 | 2 | int:ZNF408 | |
| Interaction | LRP2 interactions | 5.71e-04 | 154 | 5 | 2 | int:LRP2 | |
| Interaction | LRPAP1 interactions | 7.79e-04 | 180 | 5 | 2 | int:LRPAP1 | |
| Interaction | LRP1 interactions | 9.23e-04 | 196 | 5 | 2 | int:LRP1 | |
| Interaction | FGB interactions | 9.51e-04 | 199 | 5 | 2 | int:FGB | |
| Interaction | LCOR interactions | 1.40e-03 | 242 | 5 | 2 | int:LCOR | |
| Interaction | TIMP2 interactions | 1.83e-03 | 277 | 5 | 2 | int:TIMP2 | |
| Interaction | ARRB1 interactions | 2.20e-03 | 304 | 5 | 2 | int:ARRB1 | |
| Interaction | DISC1 interactions | 4.33e-03 | 429 | 5 | 2 | int:DISC1 | |
| Interaction | RPL10 interactions | 1.13e-02 | 702 | 5 | 2 | int:RPL10 | |
| GeneFamily | Low density lipoprotein receptors | 4.77e-07 | 13 | 2 | 2 | 634 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 1.08e-07 | 59 | 5 | 3 | M47993 | |
| Coexpression | DELYS_THYROID_CANCER_UP | 4.04e-07 | 445 | 5 | 4 | M3645 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C4 | 1.60e-06 | 11 | 5 | 2 | M566 | |
| Coexpression | LY_AGING_MIDDLE_UP | 2.65e-06 | 14 | 5 | 2 | M19146 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.77e-06 | 191 | 5 | 3 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.07e-06 | 196 | 5 | 3 | M3008 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 4.33e-06 | 200 | 5 | 3 | M5930 | |
| Coexpression | NABA_CORE_MATRISOME | 1.06e-05 | 270 | 5 | 3 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 1.12e-05 | 275 | 5 | 3 | M5884 | |
| Coexpression | NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS | 1.26e-05 | 30 | 5 | 2 | M47990 | |
| Coexpression | LIEN_BREAST_CARCINOMA_METAPLASTIC | 1.53e-05 | 33 | 5 | 2 | M11654 | |
| Coexpression | VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 | 1.93e-05 | 37 | 5 | 2 | M16643 | |
| Coexpression | BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP | 4.19e-05 | 427 | 5 | 3 | M17923 | |
| Coexpression | GERHOLD_ADIPOGENESIS_DN | 5.48e-05 | 62 | 5 | 2 | M1576 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 5.84e-05 | 64 | 5 | 2 | M2572 | |
| Coexpression | GERHOLD_ADIPOGENESIS_DN | 5.84e-05 | 64 | 5 | 2 | MM671 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 6.79e-05 | 69 | 5 | 2 | M10165 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 7.82e-05 | 74 | 5 | 2 | M13547 | |
| Coexpression | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP | 9.85e-05 | 83 | 5 | 2 | M17951 | |
| Coexpression | ZHU_CMV_24_HR_DN | 1.01e-04 | 84 | 5 | 2 | M4065 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 1.18e-04 | 91 | 5 | 2 | M40180 | |
| Coexpression | KIM_MYCN_AMPLIFICATION_TARGETS_UP | 1.24e-04 | 93 | 5 | 2 | M18532 | |
| Coexpression | ZHU_CMV_ALL_DN | 2.03e-04 | 119 | 5 | 2 | M14555 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP | 2.09e-04 | 121 | 5 | 2 | M12828 | |
| Coexpression | CHEBOTAEV_GR_TARGETS_DN | 2.20e-04 | 124 | 5 | 2 | M7876 | |
| Coexpression | CHEBOTAEV_GR_TARGETS_DN | 2.49e-04 | 132 | 5 | 2 | MM470 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP | 2.49e-04 | 132 | 5 | 2 | MM465 | |
| Coexpression | HALLMARK_COAGULATION | 2.72e-04 | 138 | 5 | 2 | M5946 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 4.52e-04 | 178 | 5 | 2 | M17079 | |
| Coexpression | WANG_CISPLATIN_RESPONSE_AND_XPC_UP | 4.89e-04 | 185 | 5 | 2 | M19511 | |
| Coexpression | NABA_MATRISOME | 5.35e-04 | 1008 | 5 | 3 | MM17056 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 5.37e-04 | 194 | 5 | 2 | M39122 | |
| Coexpression | GSE22886_IL2_VS_IL15_STIM_NKCELL_UP | 5.48e-04 | 196 | 5 | 2 | M4514 | |
| Coexpression | NABA_MATRISOME | 5.64e-04 | 1026 | 5 | 3 | M5889 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_UP | 5.71e-04 | 200 | 5 | 2 | M3705 | |
| Coexpression | GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | 5.71e-04 | 200 | 5 | 2 | M8383 | |
| Coexpression | GSE2585_THYMIC_DC_VS_MTEC_DN | 5.71e-04 | 200 | 5 | 2 | M6283 | |
| Coexpression | GSE15767_MED_VS_SCS_MAC_LN_UP | 5.71e-04 | 200 | 5 | 2 | M3584 | |
| Coexpression | WINTER_HYPOXIA_METAGENE | 8.40e-04 | 243 | 5 | 2 | M14072 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 9.68e-04 | 261 | 5 | 2 | M1834 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 1.04e-03 | 270 | 5 | 2 | M19432 | |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP | 1.14e-03 | 284 | 5 | 2 | M16975 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 1.14e-03 | 284 | 5 | 2 | MM987 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 1.75e-03 | 352 | 5 | 2 | M17471 | |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_DN | 2.33e-03 | 407 | 5 | 2 | M19541 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 3.21e-03 | 479 | 5 | 2 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 3.27e-03 | 483 | 5 | 2 | MM1082 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 6.40e-03 | 681 | 5 | 2 | M39175 | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 1.03e-04 | 69 | 5 | 2 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#3_top-relative-expression-ranked_500 | 1.16e-04 | 73 | 5 | 2 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k3_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500 | 1.21e-04 | 494 | 5 | 3 | JC_fibro_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.61e-04 | 86 | 5 | 2 | GSM777055_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_100 | 1.61e-04 | 86 | 5 | 2 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.65e-04 | 87 | 5 | 2 | GSM777050_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.96e-04 | 95 | 5 | 2 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500 | 2.40e-04 | 105 | 5 | 2 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k2 | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_2500_k-means-cluster#1 | 3.01e-04 | 672 | 5 | 3 | JC_iEC_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.79e-04 | 132 | 5 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k4 | |
| CoexpressionAtlas | gallbladder | 4.76e-04 | 148 | 5 | 2 | gallbladder | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.82e-04 | 149 | 5 | 2 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_200 | 5.84e-04 | 164 | 5 | 2 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.34e-04 | 184 | 5 | 2 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k2 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_1000 | 9.17e-04 | 981 | 5 | 3 | PCBC_ctl_BronchSmoothMuscl_1000 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000 | 9.41e-04 | 990 | 5 | 3 | JC_fibro_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.36e-03 | 251 | 5 | 2 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k2 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-07 | 175 | 5 | 3 | 21542be95059983d2c8bdf01ec711fdbf1ec1f62 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.37e-07 | 181 | 5 | 3 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.47e-07 | 182 | 5 | 3 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-07 | 184 | 5 | 3 | c9d7ec17cc5b7ba1b1e721ca392746e8f4a3d41f | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.91e-07 | 186 | 5 | 3 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-07 | 188 | 5 | 3 | 8cc927b4c51d982fdafa04dc7393617ad9bb220e | |
| ToppCell | facs-Skin-nan-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-07 | 189 | 5 | 3 | 6c71e81373cb7822de23c193a6350b6df9f567bc | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-07 | 189 | 5 | 3 | 1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-07 | 191 | 5 | 3 | 1b26056df078674f37a6c06f6256b30cfcec21a7 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-07 | 192 | 5 | 3 | b35f0e422070ba9c7c1d9ff3eace4edc10286cde | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-07 | 195 | 5 | 3 | d2c9c58b46bf96f9a536e177b995e340b55c6750 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.97e-07 | 195 | 5 | 3 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.97e-07 | 195 | 5 | 3 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.09e-07 | 196 | 5 | 3 | fcb275746bf51269ed8ba4cf93edb054a45f1ccd | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.09e-07 | 196 | 5 | 3 | 61bee32ca299219f31a30b57124e44e85b798e9f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-07 | 197 | 5 | 3 | cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.47e-07 | 199 | 5 | 3 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.58e-05 | 107 | 5 | 2 | 8bdfb603ee0e8ca667847be016a9ee5f4f1712f8 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Ifitm1_(Ifitm1)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.58e-05 | 107 | 5 | 2 | 7dda60d30c12d9ee15cda5fcbc75c317ca2d026f | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Ifitm1_(Ifitm1)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.58e-05 | 107 | 5 | 2 | 5356499561a62a80ecd7d9a260aea87bc70543fd | |
| ToppCell | -IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 7.99e-05 | 128 | 5 | 2 | dab10774bc0532a1664fd8ac2b54cffab01be55a | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.49e-05 | 132 | 5 | 2 | 893b7ec2a2d8a140cc98575d1beca1189f053e9a | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.75e-05 | 134 | 5 | 2 | a3547a68012d879d4dfe80394eace70808722e43 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.75e-05 | 134 | 5 | 2 | 9458e2d0dbc18d9025b66b59f3ecc2fbc5384940 | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 1.05e-04 | 147 | 5 | 2 | 87c24843cb0e87ad42e725d08423131a5d2d25a3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.14e-04 | 153 | 5 | 2 | 65641cc82883716dba0fefb749a30174a63f4da5 | |
| ToppCell | Basal_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.17e-04 | 155 | 5 | 2 | 30accc72a6a914ae0c4d52b373ea1c9a98efbf22 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.23e-04 | 159 | 5 | 2 | cb2470b288c13e454a2a80115b0d5613b3f718e6 | |
| ToppCell | (1)_Control_(PBS)-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 1.25e-04 | 160 | 5 | 2 | ab769516f9f7798d1390ef215caf22a2d3d53e63 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 161 | 5 | 2 | b9a17f41426bf715f30bf544a6795afaf37a3aa6 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 161 | 5 | 2 | f7a89c481f789f624102857be722c95fbeb47595 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 163 | 5 | 2 | bc37c5d9f48b16096d5313657563f3ec84028c8c | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 1.31e-04 | 164 | 5 | 2 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 165 | 5 | 2 | 570483b43ccb5831feec9337b4664814431d40b1 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 165 | 5 | 2 | b671c6a950e70f64776c2104baccb3dc2bb6a1ba | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 165 | 5 | 2 | 2026a9a07f4d314cc05c167e491312b373468e46 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-04 | 166 | 5 | 2 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-04 | 166 | 5 | 2 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 167 | 5 | 2 | 4e58f9bf1e9d47720c871776ec34513ded4de9b7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 167 | 5 | 2 | 4ae9f2c5df13463709ea880ab035965fd99e7626 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.38e-04 | 168 | 5 | 2 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 168 | 5 | 2 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.38e-04 | 168 | 5 | 2 | 26aa96b2b547d11941cb803995ea3d302ee0518c | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-04 | 169 | 5 | 2 | e09259d62cd3e42f0919f231ed1164db59b0b6c3 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-04 | 169 | 5 | 2 | 47fd4adfe54777e69a0fabf8bd34f26223f63275 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intermediate_macrophages|Liver / Manually curated celltypes from each tissue | 1.43e-04 | 171 | 5 | 2 | 25e0333743affdb662223fb5220b8a61fa02ad9f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 171 | 5 | 2 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-04 | 171 | 5 | 2 | ca2775a17b5c339c480a963953b6fa2b0731f24d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-04 | 171 | 5 | 2 | 3ad4f138d9570500cfb4423a2be16bb7d1cacbf8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 171 | 5 | 2 | effcc4b6d26eafc2ca6fa08b6fee2689eff48f0f | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|(0)_Normal/No_Treatment / Stress and Cell class | 1.46e-04 | 173 | 5 | 2 | c2a0f674681836b5a868c13f67caa7d555ef6519 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 173 | 5 | 2 | 2226505610af1becc253d0a5550627144ef0ed6b | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 1.48e-04 | 174 | 5 | 2 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-04 | 175 | 5 | 2 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 175 | 5 | 2 | 9d082ba0e350162aa6e71b668be074b12a27c7ab | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 175 | 5 | 2 | f641f34b52aec5d047430a6f9d026e915da6c11d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-04 | 176 | 5 | 2 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.51e-04 | 176 | 5 | 2 | 77c3da2eaa072a6baefb5087fd07ec18c5e271cd | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 176 | 5 | 2 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 176 | 5 | 2 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-04 | 176 | 5 | 2 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.51e-04 | 176 | 5 | 2 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-chondrocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.53e-04 | 177 | 5 | 2 | 915b848d789051a1c3bc6f6dc86955bb752276ab | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.54e-04 | 178 | 5 | 2 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.54e-04 | 178 | 5 | 2 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-04 | 178 | 5 | 2 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.54e-04 | 178 | 5 | 2 | cda7695411655bd6d0ba69e5041ca7530a9dad3a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 180 | 5 | 2 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | facs-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 180 | 5 | 2 | 72310baeed848f2c483ae986cd73d2fb2cca7feb | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 180 | 5 | 2 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.60e-04 | 181 | 5 | 2 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class | 1.60e-04 | 181 | 5 | 2 | 56ae86072858c156681507aecd1bc6cb0a3372d2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-04 | 181 | 5 | 2 | eea943fdcbef0bbaa8578f3296923e874893b405 | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.60e-04 | 181 | 5 | 2 | cc77ac0e223e012767222e45c5dcadc246d1aa7c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-04 | 181 | 5 | 2 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-04 | 181 | 5 | 2 | ab66a89f316b935d9ba1277426d976b1e9e39757 | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.60e-04 | 181 | 5 | 2 | b0fff0defba9aea6fba36e378b05a59986e2573a | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.60e-04 | 181 | 5 | 2 | ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.61e-04 | 182 | 5 | 2 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 182 | 5 | 2 | 22d6f4790950508e8aa27e02a8133af5f53f13c8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.61e-04 | 182 | 5 | 2 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-04 | 183 | 5 | 2 | 667d9107af17fd076ceff6b2cbcb78f892fd62d2 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.63e-04 | 183 | 5 | 2 | 06e4b05d86a7d643569e19575c2c9aa351d33f29 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-04 | 183 | 5 | 2 | 28e1fc6498aaf8f42c4d6d4fa54ffff4c546d0d1 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-04 | 183 | 5 | 2 | bc7dd6a40ec9c773d005c1a46f305d40cdd0a326 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 1.65e-04 | 184 | 5 | 2 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-04 | 184 | 5 | 2 | 8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 1.65e-04 | 184 | 5 | 2 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | 1.65e-04 | 184 | 5 | 2 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.67e-04 | 185 | 5 | 2 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.67e-04 | 185 | 5 | 2 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.67e-04 | 185 | 5 | 2 | 7b1c5d99bd7a6e148524029758cee244a17f5d09 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.67e-04 | 185 | 5 | 2 | e9033a03d574956cf3ae228740b3166e40a6397f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.67e-04 | 185 | 5 | 2 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.67e-04 | 185 | 5 | 2 | 578f12c6b2e33d09598dc8e022a20c8555d1325c | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.67e-04 | 185 | 5 | 2 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 1.67e-04 | 185 | 5 | 2 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-4|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.67e-04 | 185 | 5 | 2 | e1f3f0e974eb3fe1c05018beb9e124c7fb0cbe50 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-04 | 186 | 5 | 2 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.69e-04 | 186 | 5 | 2 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.10e-04 | 50 | 5 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.10e-04 | 50 | 5 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_9 | |
| Computational | Metal / Ca ion binding. | 1.48e-03 | 133 | 5 | 2 | MODULE_324 | |
| Computational | Adhesion molecules. | 1.66e-03 | 141 | 5 | 2 | MODULE_122 | |
| Computational | Genes in the cancer module 105. | 3.32e-03 | 200 | 5 | 2 | MODULE_105 | |
| Computational | ECM and collagens. | 4.18e-03 | 225 | 5 | 2 | MODULE_47 | |
| Drug | diethyl malate | 5.17e-07 | 86 | 5 | 3 | ctd:C058705 | |
| Drug | monatepil | 1.56e-05 | 29 | 5 | 2 | CID000060810 | |
| Drug | 2-methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide | 1.79e-05 | 31 | 5 | 2 | ctd:C577942 | |
| Drug | biphenylene | 2.16e-05 | 34 | 5 | 2 | CID000009214 | |
| Drug | Val-Val | 2.85e-05 | 39 | 5 | 2 | CID000107475 | |
| Drug | Epi Lovastatin | 3.26e-05 | 341 | 5 | 3 | CID000003962 | |
| Drug | HepII | 3.47e-05 | 43 | 5 | 2 | CID003036269 | |
| Drug | NC-4 | 3.64e-05 | 44 | 5 | 2 | CID006420119 | |
| Drug | 1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea | 4.33e-05 | 48 | 5 | 2 | ctd:C581572 | |
| Drug | Nor 3 | 4.71e-05 | 50 | 5 | 2 | CID009578441 | |
| Drug | simvastatin | 4.86e-05 | 390 | 5 | 3 | CID000054454 | |
| Drug | GSK1210151A | 5.09e-05 | 52 | 5 | 2 | ctd:C568713 | |
| Drug | sodium cholate | 5.56e-05 | 408 | 5 | 3 | CID000000303 | |
| Drug | chondroitin sulfate | 5.77e-05 | 413 | 5 | 3 | CID000024766 | |
| Drug | sulfite | 6.87e-05 | 438 | 5 | 3 | CID000001099 | |
| Drug | K00051 | 9.53e-05 | 71 | 5 | 2 | CID009549278 | |
| Drug | AC1L1C6C | 1.12e-04 | 77 | 5 | 2 | CID000001759 | |
| Drug | lactofen | 1.24e-04 | 81 | 5 | 2 | CID000062276 | |
| Drug | Gold Sodium Thiomalate | 1.60e-04 | 92 | 5 | 2 | ctd:D006052 | |
| Drug | Rgds Peptide | 2.13e-04 | 106 | 5 | 2 | CID000107775 | |
| Drug | pitavastatin | 2.46e-04 | 114 | 5 | 2 | CID005282451 | |
| Drug | Chr 5 | 2.96e-04 | 125 | 5 | 2 | CID006448119 | |
| Drug | trypanothione disulfide | 3.71e-04 | 140 | 5 | 2 | CID000115098 | |
| Drug | ezetimibe | 4.09e-04 | 147 | 5 | 2 | CID000150311 | |
| Drug | pyrachlostrobin | 4.27e-04 | 811 | 5 | 3 | ctd:C513428 | |
| Drug | 25-hydroxycholesterol | 4.84e-04 | 160 | 5 | 2 | CID000065094 | |
| Drug | probucol | 4.96e-04 | 162 | 5 | 2 | CID000004912 | |
| Drug | Furosemide | 5.08e-04 | 164 | 5 | 2 | ctd:D005665 | |
| Drug | Lycorine hydrochloride [2188-68-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 5.46e-04 | 170 | 5 | 2 | 6051_UP | |
| Drug | isocycloheximide | 5.89e-04 | 905 | 5 | 3 | CID000002900 | |
| Drug | AC1L1DD6 | 6.05e-04 | 179 | 5 | 2 | CID000002299 | |
| Drug | Gabexate mesilate [56974-61-9]; Up 200; 9.6uM; HL60; HT_HG-U133A | 6.12e-04 | 180 | 5 | 2 | 2937_UP | |
| Drug | Podophyllotoxin [518-28-5]; Up 200; 9.6uM; PC3; HT_HG-U133A | 6.60e-04 | 187 | 5 | 2 | 5841_UP | |
| Drug | Prednisolone [50-24-8]; Up 200; 11uM; PC3; HT_HG-U133A | 6.96e-04 | 192 | 5 | 2 | 5101_UP | |
| Drug | Hydrocortisone base [50-23-7]; Up 200; 11uM; MCF7; HT_HG-U133A | 7.10e-04 | 194 | 5 | 2 | 3284_UP | |
| Drug | Flecainide acetate [54143-56-5]; Up 200; 8.4uM; PC3; HT_HG-U133A | 7.18e-04 | 195 | 5 | 2 | 4318_UP | |
| Drug | Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 7.25e-04 | 196 | 5 | 2 | 4169_UP | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 1uM; MCF7; HT_HG-U133A | 7.32e-04 | 197 | 5 | 2 | 4715_UP | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; PC3; HT_HG-U133A | 7.32e-04 | 197 | 5 | 2 | 6664_UP | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; HL60; HT_HG-U133A | 7.32e-04 | 197 | 5 | 2 | 6161_UP | |
| Drug | Benfotiamine [22457-89-2]; Up 200; 8.6uM; HL60; HT_HG-U133A | 7.32e-04 | 197 | 5 | 2 | 2177_UP | |
| Drug | Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; HL60; HT_HG-U133A | 7.40e-04 | 198 | 5 | 2 | 2472_UP | |
| Drug | Succinylsulfathiazole [116-43-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 7.47e-04 | 199 | 5 | 2 | 4847_UP | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; PC3; HT_HG-U133A | 7.47e-04 | 199 | 5 | 2 | 4634_DN | |
| Drug | Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; PC3; HT_HG-U133A | 7.47e-04 | 199 | 5 | 2 | 4595_UP | |
| Drug | Halofantrine hydrochloride [36167-63-2]; Up 200; 7.4uM; HL60; HT_HG-U133A | 7.55e-04 | 200 | 5 | 2 | 3130_UP | |
| Drug | Artemisinin [63968-64-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 7.55e-04 | 200 | 5 | 2 | 7007_UP | |
| Drug | Clidinium bromide [3485-62-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 7.55e-04 | 200 | 5 | 2 | 6837_UP | |
| Drug | AC1L1J6H | 1.05e-03 | 236 | 5 | 2 | CID000004889 | |
| Drug | Rgd Peptide | 1.07e-03 | 239 | 5 | 2 | CID000104802 | |
| Drug | Okadaic Acid | 1.30e-03 | 263 | 5 | 2 | ctd:D019319 | |
| Drug | Methylnitronitrosoguanidine | 1.32e-03 | 265 | 5 | 2 | ctd:D008769 | |
| Drug | Calpain inhibitor I | 1.47e-03 | 280 | 5 | 2 | CID000004332 | |
| Drug | liu | 1.52e-03 | 285 | 5 | 2 | CID015991562 | |
| Drug | sulfate | 1.67e-03 | 1292 | 5 | 3 | CID000001117 | |
| Drug | 17alpha-estradiol | 1.71e-03 | 1303 | 5 | 3 | CID000000450 | |
| Disease | Microangiopathy, Diabetic | 2.75e-06 | 16 | 5 | 2 | C0025945 | |
| Disease | Diabetic Angiopathies | 2.75e-06 | 16 | 5 | 2 | C0011875 | |
| Disease | urate measurement | 8.65e-03 | 895 | 5 | 2 | EFO_0004531 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QEDSDHDGQGDACDD | 456 | P49747 | |
| HDGQGDACDDDDDND | 461 | P49747 | |
| QFVCDHDDDCGDGSD | 2821 | Q9NZR2 | |
| CNGIDECGDNSDEDH | 3736 | Q9NZR2 | |
| GDACDHDDDNDGIPD | 891 | P07996 | |
| DHDRDGQGDACDPDD | 886 | P35442 | |
| CDGDNDCGDHSDEDG | 51 | O75096 |